about
Optimizing therapeutics in the management of patients with multiple sclerosis: a review of drug efficacy, dosing, and mechanisms of actionSphingosine kinase 1 deficiency exacerbates LPS-induced neuroinflammationThe use of focus groups to characterize symptoms in persons with multiple sclerosis.Adaptive immune responses in CNS autoimmune disease: mechanisms and therapeutic opportunities.Novel therapeutic options for multiple sclerosis.Treatment against human endogenous retrovirus: a possible personalized medicine approach for multiple sclerosis.
P2860
description
2009 nî lūn-bûn
@nan
2009 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Recent developments in multiple sclerosis therapeutics
@ast
Recent developments in multiple sclerosis therapeutics
@en
type
label
Recent developments in multiple sclerosis therapeutics
@ast
Recent developments in multiple sclerosis therapeutics
@en
prefLabel
Recent developments in multiple sclerosis therapeutics
@ast
Recent developments in multiple sclerosis therapeutics
@en
P2093
P2860
P356
P1433
P1476
Recent developments in multiple sclerosis therapeutics
@en
P2093
Dennis Bourdette
Michelle H Cameron
Rebecca I Spain
P2860
P2888
P356
10.1186/1741-7015-7-74
P407
P577
2009-12-07T00:00:00Z
P5875
P6179
1043953558